SecBot SecBot
SC 13D/A ·Filed Nov 6, 2026

MDGL

MADRIGAL PHARMACEUTICALS, INC.
NEUTRAL
Impact 3/10
Horizondays Processed10d 6h ago SEC0001104659-26-124003
Activist stake amendment (position change)
Actionable Insight • Neutral

Monitor for the actual SC 13D/A filing content to determine whether the activist investor increased or decreased their stake and whether their purpose or demands changed. The recent Q3 earnings (filed 3 days prior) showed strong revenue growth and first profitable quarter, which may influence activist strategy.

DirectionNeutral
Confidencelow
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$432.79
T+0 close · Nov 6, 2026 · via day close
Latest settled
−2.04%
T+5 · $423.96
Vs SPY
−0.35%
α at T+5
Next horizon
T+20
in 21d
  1. T+0 · Nov 9 $432.79entry
  2. T+1 · 7d ago −0.04%α +0.32% · $432.60
  3. T+5 · 18h ago −2.04%α −0.35% · $423.96
  4. T+20 · in 21d Pending
  5. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Analysis based on filing metadata only; document content was unavailable. This is an amendment to a Schedule 13D for Madrigal Pharmaceuticals, filed on November 6, 2026. Without the actual filing content, the activist's updated position, purpose, and intentions cannot be determined.

Key Facts

  • Filing type: SC 13D/A (amended beneficial ownership report)
  • Filed: November 6, 2026
  • Company: Madrigal Pharmaceuticals (MDGL)
  • Document content was unavailable for analysis

Financial Impact

Unknown, filing content unavailable

Risk Factors

  • Filing content unavailable, analysis is based on metadata only
  • Activist's updated position and intentions are unknown

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (26 analysts)

Investment Themes

Documents Analyzed

Report based on filing metadata.

Track record

18 reports on MDGL

Performance horizon

3 of 6 bullish or bearish reports moved the stock their way by T+5. Best: +10.26% at T+20 after the Jul 30, 2026 report. 3 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $424.08 Now $423.96 −0.03% settles Nov 23
  2. Nov 6, 202610d ago SC 13D/A Neutral 3/10 Viewing Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
  3. Nov 6, 202610d ago Insider Buy Bullish 5/10 Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
  4. Nov 6, 202610d ago Insider Cluster Bullish 5/10 Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
  5. Nov 6, 202610d ago 144 Neutral 2/10 Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
  6. Nov 5, 202611d ago Institutional Cluster Mixed 3/10 Entry $400.10 to $425.21 Now $423.96 +5.96% ▲ +6.28% +2.99% vs SPY
  7. Nov 5, 202611d ago Press Release Bullish 5/10 Entry $400.10 to $425.21 Now $423.96 +5.96% ▲ +6.28% +2.99% vs SPY
  8. Nov 3, 202613d ago 8-K Bullish 7/10 No price data
  9. Nov 3, 202613d ago Press Release Bullish 6/10 Entry $396.32 to $432.60 Now $423.96 +6.97% ▲ +9.15% +9.74% vs SPY
  10. Aug 12, 202613w ago 8-K Neutral 3/10 Entry $536.20 to $540.16 Now $423.96 −20.93% ▲ +0.74% +1.18% vs SPY
Showing 10 of 18

US Market Status

Market Closed · Opens in 8h 14m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 6, 2026